retatrutide treatment duration clinical trials First-in-Class 'Triple-G'! Retatrutide, a first-in-class GIP, GLP-1 & Glucagon triple hormone receptor agonist drug leads to nearly 29% weight loss in first pivotal test! Eli Lilly announced positive topline results from the SyncedWithC4 What if GLP-1s could PENS & Vials:60mg pen

retatrutide treatment duration clinical trials First-in-Class 'Triple-G'! Retatrutide, a first-in-class GIP, GLP-1 & Glucagon triple hormone receptor agonist drug leads to nearly 29% weight loss in first pivotal test! Eli Lilly announced positive topline results from the SyncedWithC4 What if GLP-1s could PENS & Vials:60mg pen

What if GLP-1s could also treat addiction? A listener called in and told us they lost the urge to drink when they started a GLP-1. And other people are experiencing this too.

Findings from 10 studies reviewed The results of 10 eligible research studies are summarized in Table 1

SyncedWithC4

PENS & Vials:60mg pen

Purchasing retatrutide from unregulated online sources carries serious health and legal risks